Skip to main content

Web Exclusives

FDA Approvals, In the News, Lung Cancer, Oncology
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Read More
FDA Approvals, In the News
March 08, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Read More
FDA Approvals, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
FDA Approvals, In the News
February 1, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Read More
Press Releases, Original Research
Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors
Read More
Press Releases
Access Market Intelligence Introduces Online Glossary of Common Drug Related Terms and Acronyms as e-Book
Read More
Page 21 of 37
Results 201 - 210 of 368